Cochrane Abstracts
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antifibrinolytics (lysine Analogues) for the Prevention of Bleeding in People With Haematological Disorders." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders.
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders. Accessed September 11, 2026.
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders
Antifibrinolytics (lysine Analogues) for the Prevention of Bleeding in People With Haematological Disorders [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 September 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
ID - 438444
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438444/all/Antifibrinolytics__lysine_analogues__for_the_prevention_of_bleeding_in_people_with_haematological_disorders
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
